Quentis Therapeutics

SATUSLOTS: Agen Resmi Raja Slot88 Gacor Gampang Menang & Situs Slot Online Terpercaya Mudah Cashback 2026

New York, United States · $49.0M raised

Headquarters
New York
Business Model
B2B
Total Funding
$49.0M
Last Round
$1.0M GrantDec 2018
Rounds
2

About

Quentis Therapeutics is a preclinical stage biotechnology company translating novel biology into new therapeutic approaches to help more cancer patients benefit from immunotherapy. Based on deep expertise in endoplasmic reticulum (ER) stress biology and the tumor microenvironment, Quentis is pioneering first-in-class ER stress response modulators to boost the immune system's ability to fight cancer, with its lead program a first-in-class IRE1α inhibitor.

Summary

Quentis Therapeutics is a Biotech company based in New York, United States. It has raised $49.0M in total across 2 rounds, most recently a $1.0M Grant round in Dec 2018. Investors include Polaris Partners and Versant Ventures.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

GrantLifeSci NYC Expansion Space Fund AwardDec 2018
$1.0M

Sign up to see all 2 rounds

Series A through Grant — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Quentis Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/quentis-therapeutics"><img src="https://indexed.vc/api/badge/company/quentis-therapeutics" alt="Quentis Therapeutics on Indexed.vc" width="260" height="76" /></a>